Search results
2 Unexpected Advantages of CDs Over Savings Accounts
The Motley Fool via AOL· 9 hours agoAnd I can totally see why. Today's CD rates are the highest they've been in years, with some products paying upward of 5%. And while you might earn a...
What is a jumbo CD? (Spoiler: Bigger isn't always better)
AOL· 4 days agoDig deeper: High-yield savings account vs. CD: What to know when rates are high...
New CD Rate Leader Is a Large U.S. Bank That's Available Nationwide
Investopedia· 7 days agoOn Friday, BMO Alto boosted its rates for CD terms of 3 years and longer, and its new 5-year return...
6 Do’s and Don’ts When Using CDs for Retirement - NerdWallet
Nerdwallet· 6 days agoNerdWallet, Inc. does not offer advisory or brokerage services, nor does it recommend or advise...
What Is a Bank Failure? Definition and List of Failed Banks - NerdWallet
Nerdwallet· 4 days agoWhat is a bank failure? A bank failure is the closure of a bank by a government regulator generally...
What Is a Regional Bank? - NerdWallet
Nerdwallet· 5 days agoA regional bank is a midsize bank that meets certain asset requirements and often serves a particular region. Here’s a guide to regional banks and how...
3 Passive Income Dividend Stocks To Buy in May
247wallst.com· 3 days agoDividend stocks historically comprise as much as 33% of S&P 500 returns. Access our free report on two high dividend stocks here. Certificates of Deposit
Asia Rides Wall St Rally, Dollar Sags on US Inflation Relief
US News & World Report· 5 days agoAsian stock markets rallied on Thursday, buoyed by Wall Street's surge to all-time peaks overnight after a milder U.S. inflation report raised expectations the Federal Reserve will deliver at ...
Dimensional Fund Advisors LP Raises Position in Marriott Vacations Worldwide Co. (NYSE:VAC)
ETF DAILY NEWS· 1 day agoDimensional Fund Advisors LP increased its position in shares of Marriott Vacations Worldwide Co....
BridgeBio Pharma (NASDAQ:BBIO) Upgraded by Evercore ISI to “Strong-Buy”
ETF DAILY NEWS· 5 days agoEvercore ISI upgraded shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) to a strong-buy rating in a research report released on Monday, Zacks.com reports. Several other analysts have also ...